OPCH vs. AMED, BTSG, CHE, ADUS, APLS, BLCO, BBIO, LNTH, HAE, and OGN
Should you be buying Option Care Health stock or one of its competitors? The main competitors of Option Care Health include Amedisys (AMED), BrightSpring Health Services (BTSG), Chemed (CHE), Addus HomeCare (ADUS), Apellis Pharmaceuticals (APLS), Bausch + Lomb (BLCO), BridgeBio Pharma (BBIO), Lantheus (LNTH), Haemonetics (HAE), and Organon & Co. (OGN). These companies are all part of the "medical" sector.
Option Care Health (NASDAQ:OPCH) and Amedisys (NASDAQ:AMED) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.
In the previous week, Option Care Health had 3 more articles in the media than Amedisys. MarketBeat recorded 6 mentions for Option Care Health and 3 mentions for Amedisys. Amedisys' average media sentiment score of 1.70 beat Option Care Health's score of 1.49 indicating that Amedisys is being referred to more favorably in the news media.
Option Care Health has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.
Option Care Health currently has a consensus target price of $40.00, indicating a potential upside of 34.32%. Amedisys has a consensus target price of $100.80, indicating a potential upside of 6.75%. Given Option Care Health's stronger consensus rating and higher possible upside, research analysts plainly believe Option Care Health is more favorable than Amedisys.
Amedisys received 449 more outperform votes than Option Care Health when rated by MarketBeat users. However, 58.97% of users gave Option Care Health an outperform vote while only 58.93% of users gave Amedisys an outperform vote.
Option Care Health has a net margin of 6.15% compared to Amedisys' net margin of -0.91%. Option Care Health's return on equity of 18.92% beat Amedisys' return on equity.
Option Care Health has higher revenue and earnings than Amedisys. Amedisys is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.
98.1% of Option Care Health shares are held by institutional investors. Comparatively, 94.4% of Amedisys shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Comparatively, 1.8% of Amedisys shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Option Care Health beats Amedisys on 14 of the 18 factors compared between the two stocks.
Get Option Care Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Option Care Health Competitors List
Related Companies and Tools
